JNJ

234.31

+0.56%↑

ISRG

478.08

-0.13%↓

ABT

108.15

-0.74%↓

RDY

13.99

+1.3%↑

NEOG

10.53

+2.53%↑

JNJ

234.31

+0.56%↑

ISRG

478.08

-0.13%↓

ABT

108.15

-0.74%↓

RDY

13.99

+1.3%↑

NEOG

10.53

+2.53%↑

JNJ

234.31

+0.56%↑

ISRG

478.08

-0.13%↓

ABT

108.15

-0.74%↓

RDY

13.99

+1.3%↑

NEOG

10.53

+2.53%↑

JNJ

234.31

+0.56%↑

ISRG

478.08

-0.13%↓

ABT

108.15

-0.74%↓

RDY

13.99

+1.3%↑

NEOG

10.53

+2.53%↑

JNJ

234.31

+0.56%↑

ISRG

478.08

-0.13%↓

ABT

108.15

-0.74%↓

RDY

13.99

+1.3%↑

NEOG

10.53

+2.53%↑

Search

ResMed Inc

Chiusa

SettoreSettore sanitario

262.42 4.55

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

251.38

Massimo

264.55

Metriche Chiave

By Trading Economics

Entrata

-31M

349M

Vendite

-12M

1.3B

P/E

Media del settore

26.175

90.422

Rendimento da dividendi

0.87

Margine di Profitto

26.096

Dipendenti

10,600

EBITDA

-29M

503M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+18.02% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

0.87%

2.13%

Utili prossimi

22 apr 2026

Prossima data del Dividendo

19 mar 2026

Prossima data del' Ex Dividendo

12 feb 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-539M

37B

Apertura precedente

257.87

Chiusura precedente

262.42

Notizie sul Sentiment di mercato

By Acuity

9%

91%

8 / 352 Classifica in Healthcare

ResMed Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

3 feb 2026, 23:11 UTC

I principali Market Mover
Acquisizioni, Fusioni, Takeovers

Silicon Laboratories Shares Up On Report of $7 Billion Texas Instruments Acquisition Deal

3 feb 2026, 23:50 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

3 feb 2026, 23:50 UTC

Discorsi di Mercato

Nikkei May Decline After Hitting All-Time High -- Market Talk

3 feb 2026, 23:42 UTC

Discorsi di Mercato

Gold Edges Lower on Possible Technical Correction -- Market Talk

3 feb 2026, 23:41 UTC

Acquisizioni, Fusioni, Takeovers

KKR Makes AI Play With $10.9B Asia Data-Center Deal

3 feb 2026, 23:38 UTC

Utili

AMD Sales Climb on Help From Data-Center Business -- Update

3 feb 2026, 23:29 UTC

Acquisizioni, Fusioni, Takeovers

KKR-Consortium Deal in STT GDC Is One of the Largest Digital-Infrastructure Transactions in Southeast Asia

3 feb 2026, 23:27 UTC

Acquisizioni, Fusioni, Takeovers

Netflix, Warner Defend Proposed Deal in Senate Hearing -- WSJ

3 feb 2026, 23:25 UTC

Acquisizioni, Fusioni, Takeovers

KKR-Consortium Expects Deal to Close by Early 2H of 2026

3 feb 2026, 23:23 UTC

Acquisizioni, Fusioni, Takeovers

KKR Consortium With Singtel to Own 75% and 25% Stake in ST Telemedia Global Data Centres

3 feb 2026, 23:22 UTC

Acquisizioni, Fusioni, Takeovers

KKR-Led Consortium to Buy Singapore-Based Global Data-Center Provider Valued at S$13.8B

3 feb 2026, 23:19 UTC

Discorsi di Mercato

Australia Gold Miners Tipped to Rally Higher -- Market Talk

3 feb 2026, 23:19 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

3 feb 2026, 22:56 UTC

I principali Market Mover
Acquisizioni, Fusioni, Takeovers

Silicon Laboratories Shares Up On Report of $7B Texas Instruments Acquisition Deal

3 feb 2026, 22:40 UTC

Utili

Amdocs Extends Collaboration With T-Mobile

3 feb 2026, 22:39 UTC

Utili

Amdocs 1Q Adj EPS $1.81

3 feb 2026, 22:39 UTC

Utili

Amdocs 1Q Rev $1.16B

3 feb 2026, 22:39 UTC

Utili

Amdocs 1Q EPS $1.45 >

3 feb 2026, 22:38 UTC

Utili

Amdocs: Shimie Hortig to Succeed Shuky Sheffer as President and CEO, Effective March 31

3 feb 2026, 22:30 UTC

Acquisizioni, Fusioni, Takeovers

Bob Iger's Second Time as CEO Wasn't Great for the Stock. He Still Leaves Behind A Strong Legacy. -- Barrons.com

3 feb 2026, 22:22 UTC

Acquisizioni, Fusioni, Takeovers

Texas Instruments Nearing $7B Deal for Silicon Laboratories, Sources Tell FT

3 feb 2026, 22:14 UTC

Utili

AMD Expects to Scale AI Business to Tens of Billions in Annual Sales in 2027, CEO Says

3 feb 2026, 22:13 UTC

Utili

AMD Expects Data-Center Unit Sales to Jump More Than 60% a Year Over Next Three to Five Years, CEO Says

3 feb 2026, 22:12 UTC

Utili

AMD in Talks With Several Companies About At-Scale, Multi-Year Chip Deployments, CEO Says

3 feb 2026, 22:10 UTC

Utili

AMD CEO: Eight of 10 Biggest AI Companies Use Instinct Chip to Power Production Workloads

3 feb 2026, 22:10 UTC

Utili

Blackstone Stock, Alternative Managers, BDCs Dive as Software Woes Infect Private Credit -- Barrons.com

3 feb 2026, 22:10 UTC

Discorsi di Mercato

Key Drivers Underpinning Shaw's Bullish View of Gold Intact -- Market Talk

3 feb 2026, 22:10 UTC

Utili

AMD CEO: Enterprises Are Modernizing Data Centers to Have Compute Needed for New AI Workflows

3 feb 2026, 22:09 UTC

Utili

AMD CEO: Hyperscalers Expanding Infrastructure to Meet Growing Cloud-Services Demand in AI

3 feb 2026, 22:09 UTC

Utili

AMD CEO: Demand Accelerated Across Data Center, Gaming and PC

Confronto tra pari

Modifica del prezzo

ResMed Inc Previsione

Obiettivo di Prezzo

By TipRanks

18.02% in crescita

Previsioni per 12 mesi

Media 300.64 USD  18.02%

Alto 345 USD

Basso 265 USD

Basato su 13 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per ResMed Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

13 ratings

8

Acquista

5

Mantieni

0

Vendi

Sentiment

By Acuity

8 / 352 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat